Iris neovascularization

Bader described the iris neovascularization in 1868, and many authors have subsequently reported iris neovascularization in patients with diabetes and central retinal vein occlusion. Due to the advancement of examination technology, especially the clinical application of fluorescent angiography, the discovery of iris neovascularization is increasing. Iris neovascularization is not a primary disease of the iris, but secondary to many eye diseases and some systemic diseases. Because it can develop into or merge with the formation of fibrous vascular membranes, resulting in severe neovascular glaucoma due to the closure of the iris corneal corners, the intraocular pressure is often difficult to control, eventually suffering from blindness, and even removing the eyeballs due to severe eye pain. Therefore, it is important to detect and deal with it early.

The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.